A

Alterra Labs

AI-enabled pre-bill chart review platform

Overview

Alterra Labs, doing business as ChartR Health, builds human-AI integrated solutions for healthcare data challenges. Its platform plugs into existing health IT and workflows to perform pre-bill reviews of patient charts using proprietary AI. It surfaces revenue opportunities, coding mistakes, and clinical quality issues in real time, with evidence-based justifications, before claims are submitted. The system focuses on revenue integrity, denial prevention, and audit/compliance, aiming to increase RVUs by identifying missed coding and to prevent denials and enable 100% pre-bill audit coverage according to custom criteria. The tool augments current systems rather than replaces them, providing actionable insights that help healthcare providers maximize revenue, stay compliant, and operate more efficiently.

Work here?Claim your company

About Alterra Labs

Simplify's Rating
Why Alterra Labs is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & AnalyticsEnterprise SoftwareAI & Machine LearningHealthcare

Company Size

11-50

Company Stage

Seed

Total Funding

$12.5M

Headquarters

New York City, United States

Founded

2025

Get referred to Alterra Labs

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • Fortune reported several frontier AI labs already pay for Alterra’s medical simulations.
  • The November 2026 seed round gives Alterra capital to expand clinical scenarios and sales.
  • TrustX Health participation positions Alterra inside emerging agentic-AI safety standards.

What critics are saying

  • Frontier labs can inhouse simulation tooling, commoditizing Alterra before 2027.
  • Healthcare buyers demand regulatory proof; one failed validation can freeze enterprise sales cycles.
  • If model makers standardize on internal eval stacks, Alterra loses its core customer base.

What makes Alterra Labs unique

  • Alterra Labs builds simulated clinical workflows, not generic medical chatbots, since 2025.
  • Clinicians and scientists score failures, turning judgment errors into reinforcement-learning training signals.
  • Oak HC/FT backed its November 10, 2026 seed round, validating healthcare credibility.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$12.5M

Above

Industry Average

Funded Over

1 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Above Average

Industry standards

$3.3M
$2M
$2.3M
$3M
$12.5M

Company News

Fortune
Nov 10th, 2026
Alterra Labs raises $12.5M seed round to train medical AI in simulated clinical environments

Alterra Labs, a New York startup that builds simulated medical environments to test and train AI models, has raised a $12.5 million seed round. Oak HC/FT led the round, with Flare Capital Partners and Company Ventures participating. The company tests models on medical tasks, finds where they fail, and turns those failures into training exercises. Doctors and scientists help design the tasks and judge the models' decisions, and their assessments become scoring criteria for reinforcement learning. Founder and chief executive officer Akash Kapoor said models can learn to operate software but still lack clinical judgment. "It has a lot of knowledge," he said. "It lacks a lot of judgment." Kapoor started the company in 2025 while at Columbia Medical School. Frontier AI labs are its fastest-growing customer group, and it earns revenue from training environments and post-training services.

Recently Posted Jobs

Sign up to get curated job recommendations

Alterra Labs is Hiring for 3 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs